Companies
/Healthcare
Xencor Inc
$26.90
▼ $1.01 (−3.62%) today
Markets closed · 1:16am ET
Today · % change
Fundamentals
Market Cap
$2.1B
Profit Margin
-155.6%
Revenue (TTM)
$105.0M
EPS (TTM)
$-2.21
52-Week Range
$8 – $31
Street Target
$29.00
About Xencor
Xencor Inc is a pioneering biopharmaceutical company based in Pasadena, California, dedicated to developing innovative antibody and cytokine therapeutics for cancer and autoimmune diseases. With a robust pipeline, Xencor has introduced treatments like Sotrovimab for COVID-19 and Ultomiris for blood disorders. The company is also advancing research in promising areas such as bispecific antibodies and treatments for solid tumors and autoimmune conditions. Through strategic partnerships, Xencor continues to push the boundaries of medicine to improve patient care.